Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe?

Health Policy

Volumn 101, Issue 2, 2011, Pages 146-152

  Dylst, Pieter ^a   Vulto, Arnold ^b   Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Europe; Generics; Pharmaceutical; Public procurement; Tendering

Indexed keywords

GENERIC DRUG;

AMBULATORY CARE; ARTICLE; DRUG INDUSTRY; EUROPE; EUROPEAN UNION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; NORWAY; OUTPATIENT; PRESCRIPTION; QUESTIONNAIRE;

AMBULATORY CARE; DIFFUSION OF INNOVATION; EUROPEAN UNION; HEALTH CARE SURVEYS; NORWAY; PRESCRIPTION DRUGS;

EID: 79957975019     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2011.03.004     Document Type: Article

References (19)

1. Cutler D., Deaton A., Llerar-Muney A. The determinants of mortality. Journal of Economic Perspectives 2006, 20:97-120.
2. Godman B., Shrank W., Wettermark B., Andersen M., Burkhardt T., Garuolienè K., et al. Use of generics - a critical cost containment measure for all healthcare professionals in Europe?. Pharmaceuticals 2010, 1:2470-2494.
3. Crown W.H., Ling D., Berndt E. Measuring the costs and benefits of pharmaceutical expenditures. Expert Reviews of Pharmacoeconomics & Outcomes Research 2002, 2:467-475.
4. Simoens S., De Coster S. Sustaining generic medicines markets in Europe 2002, Katholieke Universiteit Leuven, Leuven, [accessed 04.08.10]. http://www.egagenerics.com/.
5. Directive 2004/27/EC of the European Parliament and of the Council of 31st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 2006, 136:34-57.
6. Carradinha H. Tendering short-term pricing policies and the impact on patients, governments and the sustainability of the generic medicines industry. Journal of Generic Medicines 2009, 6:351-361.
7. Kanavos P., Seeley L., Vandoros S. Tender systems for outpatient pharmaceuticals in the European Union: evidence from the Netherlands, Germany and Belgium 2009, London School of Economics, London.
8. Leopold C., Habl C., Vogler S. Tendering of pharmaceuticals in EU member states and EEA countries. Results from the country survey 2009, ÖBIG Forschungs-und Planungsgesellschaft mbH, Vienna.
9. OXERA Tendering for medicines in New Zealand 2007, OXERA Consulting Ltd, Department of Health, Oxford.
10. MacKay P. Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?. The New Zealand Medical Journal 2005, 118(1214):U1433.
11. Price Waterhouse Coopers Ontario public drug programs competitive agreement initiative 2009, Price Waterhouse Coopers, Ottawa.
12. European Generic Medicines Association 2009 market review 2009, European Generic Medicines Association, Brussels.
13. Simoens S. International comparison of generic medicine prices. Current Medical Research and Opinion 2007, 23:2647-2654.
14. Directive 2004/18/EC of the European Parliament and of the Council of 31st March 2004 on the coordination of procedures for the award of public works contracts, public supply contracts and public service contracts. Official Journal of the European Union L 2004, 134:114-239.
15. Apotex Press release January 2009.
16. Boonen L., van der Geest S., Schut F., Varkevisser M. Pharmaceutical policy in the Netherlands: from price regulation towards managed competition in 'Pharmaceutical Markets and Insurance Worldwide'. Advances in Health Economics and Health Services Research 2010, 22:53-76.
17. Arickx F., Bormans V., Leveque F., Mortier M., Soete E., Vanhaeren E. Public tendering for off patent medicines in Belgium - the simvastatin case 2009, RIZIV, Brussels.
18. Maarse H. Drug preference policy. Health policy monitor 2009 2009, http://www.hpm.org/survey/nl/a14/1.
19. Hoffmann F., Glaeske G., Pfannkuche M.S. The effect of introducing rebate contracts to promote generic drug substitution, on doctor's prescribing practices. Deutsches Ärzteblatt International 2009, 106:783-788.